Article Information
History
- January 15, 2022.
Article Versions
- You are currently viewing Version 1 of this article (January 15, 2022 - 06:24).
- View Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.
Author Information
- Daniel Freilich, MD1,*,
- Jennifer Victory, RN, BS2,
- Paul Jenkins, PhD2,
- James Wheeler, MD3,
- G. Matthew Vail, MD4,
- Erik Riesenfeld, MD1,
- Peggy Cross2,
- Catherine Gilmore, RN2,
- Melissa Huckabone, RN2,
- Anna Schworm, RN2,
- Umesha Boregowda, MD1,
- Farah Deshmukh, MD1,
- Yuri Choi, MD1,
- Azkia Khan, MD1 and
- Anne Gadomski, MD, MPH2
- 1Bassett Medical Center (Cooperstown, NY, USA)
- 2Bassett Research Institute (Cooperstown, NY, USA)
- 3Goshen Health (Goshen, IN, USA)
- 4Reid Health (Richmond, IN, USA)
- ↵*Corresponding Author:
Daniel Freilich, MD, Bassett Medical Center, 1 Atwell Rd, Cooperstown, NY 13326 (USA). daniel.freilich{at}bassett.org
Authors’ contributions: DF conceived of the study. DF, JV, and AG initiated the study design and DF, JV, JW, GMV, ER, PC, CG, MH, AS, UB, FD, YC, AK, and AG helped with implementation.
FD, YC, and AK are grant holders.
PJ provided statistical expertise in clinical trial design and in conducting the primary statistical analysis.
All authors contributed to refinement of the study protocol and approved the final manuscript.
Posted January 15, 2022.
COVID MED – An Early Pandemic Trial of Losartan for Hospitalized COVID-19 Patients
Subject Area
Reviews and Context
0
Comment
0
TRIP Peer Reviews
0
Community Reviews
0
Automated Services
0
Blogs/Media
Author Videos